xanthine has been researched along with probucol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Makita, S; Oshima, K; Wajima, T | 1 |
Gnanadesikan, S; Houston, SA; Kennedy, S; Ugusman, A | 1 |
2 other study(ies) available for xanthine and probucol
Article | Year |
---|---|
Direct vascular effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Topics: Animals; Aorta, Thoracic; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Fetal Blood; Hydroxymethylglutaryl-CoA Reductase Inhibitors; L-Lactate Dehydrogenase; Male; Mevalonic Acid; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Pravastatin; Probucol; Pyridines; Rabbits; Simvastatin; Swine; Xanthine; Xanthine Oxidase | 2003 |
An investigation of the antiplatelet effects of succinobucol (AGI-1067).
Topics: Adenosine Diphosphate; Animals; Antioxidants; Blood Platelets; Blood Pressure; Collagen; Heart Rate; Iliac Artery; Male; Myography; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet-Rich Plasma; Probucol; Rabbits; Rats; Rats, Sprague-Dawley; Tissue Culture Techniques; Xanthine; Xanthine Oxidase | 2017 |